Enhanced RBC Aggregation in Type 2 Diabetes Patients

被引:18
|
作者
Li, Qing [1 ]
Li, Li [2 ]
Li, Yong [1 ]
机构
[1] Shanghai Ctr Clin Lab, Shanghai, Peoples R China
[2] Yueyang Hosp Integrated Tradit Chinese & Western, Shanghai, Peoples R China
关键词
erythrocyte sedimentation rate; RBC aggregation; HbA(1c); T2DM; BLOOD-CELL AGGREGATION; ERYTHROCYTE AGGREGATION; GLYCOSYLATED HEMOGLOBIN; SEDIMENTATION-RATE; MELLITUS;
D O I
10.1002/jcla.21784
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: This study aimed to investigate the relationship between HbA(1c) and RBC aggregation in type 2 diabetes mellitus (T2DM) patients by analysis of data from routine clinical tests and from in vitro experiments. Methods: A total of 2,111 inpatients with type 2 diabetes were selected and among them, 364 patients (Group A) had limited influence of plasma proteins on erythrocyte sedimentation rate (ESR) and was compared with the rest of the 1,747 inpatients (Group B). ESR, HbA(1c), WBC, CRP, Fbg, and HCT were measured in all samples. Sixty samples were also collected from T2DM patients and used for in vitro ESR studies. Spearman's correlation coefficients were employed to reflect the correlation between ESR and other parameters. Mann-Whitney U test was used to compare the study parameters. Results: The test results for Group A were lower than Group B with respect to ESR, age, HCT, HbA(1c), CRP, WBC, and Fbg. Only the difference in HbA(1c), CRP, and Fbg values had statistical significance (P < 0.05). In addition, HbA(1c) correlated better with ESR for Group A (R = 0.622) than Group B (R = 0.563), whereas CRP and Fbg were contrary to this. In the in vitro studies, the HbA(1c) values were classified into the subgroups of 6.5-8.0%, 8.1-10%, and > 10%. The corresponding ESR values were 28 +/- 5.1 mm/h, 33 +/- 2.7 mm/h, and 40 +/- 4.1 mm/h, respectively. Conclusion: ESR results of T2DM patients were elevated that was mainly caused by Fbg levels, and in addition HbA(1c) in part contributed to RBC aggregation. (C) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:387 / 389
页数:3
相关论文
共 50 条
  • [21] Glucosamine effects on platelet aggregation of type 2 diabetes mellitus patients: in vitro assays
    Belem, Gallegos-Velasco Itandehui
    Aengel, Perez-Acevedo Miguel
    Berenice, Fernandez-Rojas
    Antonio, Hernandez-Cruz Pedro
    Jesus, Hernandez-Juarez
    CELLULAR AND MOLECULAR BIOLOGY, 2023, 69 (04) : 46 - 52
  • [22] COMPARISON BETWEEN LIGHT REFLECTOMETRY AND VISCOMETRY FOR RBC AGGREGATION ASSESSMENT IN DIABETES
    OTHMANE, A
    BITBOL, M
    BUCHERER, C
    MILLS, P
    SNABRE, P
    LACOMBE, C
    LELIEVRE, JC
    CLINICAL HEMORHEOLOGY, 1985, 5 (05): : 561 - 572
  • [23] THE DEFORMABILITY AND AGGREGATION OF RBC IN CHILDREN WITH THE TYPE-A VIRUS HEPATITIS
    BALIKIN, VF
    APHINOGENOVA, NA
    NASAROV, SB
    PACHROVA, OA
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 922 - 922
  • [24] Tomato juice and platelet aggregation in type 2 diabetes
    Lazarus, SA
    Bowen, K
    Garg, ML
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (07): : 805 - 806
  • [25] Analysis of Readiness for enhanced health literacy in patients with type 2 diabetes mellitus
    de Almeida, Jocelha Maria Costa
    Serra, Eliana Brugin
    Pascoal, Livia Maia
    Santos Neto, Marcelino
    Moreira, Rafaella Pessoa
    Rolim, Isaura Leticia Tavares Palmeira
    INTERNATIONAL JOURNAL OF NURSING KNOWLEDGE, 2024, 35 (01) : 75 - 82
  • [26] CONFORMATION OF RBC GLYCOCALYX AS AN INFLUENTIAL FACTOR OF RBC AGGREGATION
    BAUMLER, H
    LERCHE, D
    MEIER, W
    BIORHEOLOGY, 1986, 23 (02) : 155 - 155
  • [27] Rosiglitazone reduces platelet aggregation in type 2 diabetes mellitus
    Pacheco, GS
    Miller, L
    Davis-Gorman, G
    McDonagh, P
    FASEB JOURNAL, 2006, 20 (04): : A297 - A298
  • [28] Cosegregation of obesity with familial aggregation of type 2 diabetes mellitus
    Ramachandran, A
    Snehalatha, C
    Satyavani, K
    Sivasankari, S
    Vijay, V
    DIABETES OBESITY & METABOLISM, 2000, 2 (03): : 149 - 154
  • [29] Familial aggregation of Type 2 diabetes in isolated Dutch population
    de Visser, CL
    Te Meerman, GJ
    Meyboom-de Jong, B
    Brouwer, H
    de Visser, W
    Bilo, HJG
    DIABETOLOGIA, 2002, 45 : A56 - A56
  • [30] Effects of gliclazide on platelet aggregation and the plasminogen activator inhibitor type 1 level in patients with type 2 diabetes mellitus
    Konya, Hiroyuki
    Hasegawa, Yoshikazu
    Hamaguchi, Tomoya
    Satani, Kahori
    Umehara, Akiko
    Katsuno, Tomoyuki
    Ishikawa, Tetsuya
    Miuchi, Masayuki
    Kohri, Kousuke
    Suehiro, Akira
    Kakishita, Eizo
    Miyagawa, Jun-ichiro
    Namba, Mitsuyoshi
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2010, 59 (09): : 1294 - 1299